首页> 美国卫生研究院文献>Polymers >Biocompatible Chitosan Oligosaccharide Modified Gold Nanorods as Highly Effective Photothermal Agents for Ablation of Breast Cancer Cells
【2h】

Biocompatible Chitosan Oligosaccharide Modified Gold Nanorods as Highly Effective Photothermal Agents for Ablation of Breast Cancer Cells

机译:生物相容性壳聚糖寡糖修饰金纳米棒作为消融乳腺癌细胞的高效光热剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Photothermal therapy (PTT) using biocompatible nanomaterials have recently attracted much attention as a novel candidate technique for cancer therapy. In this work we report the performance of newly synthesized multidentate chitosan oligosaccharide modified gold nanorods (AuNRs-LA-COS) as novel agents for PTT of cancer cells due to their excellent biocompatibility, photothermal stability, and high absorption in the near-infrared (NIR) region. The AuNRs-LA-COS exhibit a strong NIR absorption peak at 838 nm with a mean length of 26 ± 3.1 nm and diameter of 6.8 ± 1.7 nm, respectively. The temperature of AuNRs-LA-COS rapidly reached 52.6 °C for 5 min of NIR laser irradiation at 2 W/cm2. The AuNRs-LA-COS had very low cytotoxicity and exhibited high efficiency for the ablation of breast cancer cells in vitro. The tumor-bearing mice were completely ablated without tumor recurrence after photothermal treatment with AuNRs-LA-COS (25 µg/mL) under laser irradiation. In summary, this study demonstrated that AuNRs-LA-COS with laser irradiation as novel agents pave an alternative way for breast cancer therapy and hold great promise for clinical trials in the near future.
机译:最近,使用生物相容性纳米材料的光热疗法(PTT)作为一种新型的癌症治疗候选技术备受关注。在这项工作中,我们报告了新合成的多齿壳聚糖寡糖修饰的金纳米棒(AuNRs-LA-COS)作为癌细胞PTT的新型试剂的性能,这归因于其优异的生物相容性,光热稳定性和在近红外(NIR)的高吸收)地区。 AuNRs-LA-COS在838 nm处显示出很强的NIR吸收峰,平均长度分别为26±3.1 nm和6.8±1.7 nm。在2 W / cm 2 的NIR激光照射下,AuNRs-LA-COS的温度在5分钟内迅速达到52.6°C。 AuNRs-LA-COS具有非常低的细胞毒性,并且在体外消融乳腺癌细胞方面显示出很高的效率。用AuNRs-LA-COS(25 µg / mL)在激光照射下进行光热处理后,完全消融了荷瘤小鼠,没有肿瘤复发。总而言之,这项研究表明以激光辐照作为新药的AuNRs-LA-COS为乳腺癌治疗铺平了道路,并在不久的将来为临床试验带来了希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号